The safety of celecoxib in ankylosing spondylitis treatment

Author： Poddubnyy Denis A   Song In-Ho   Sieper Joachim  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.7, Iss.4, 2008-07, pp. : 401-409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etoricoxib and the treatment of ankylosing spondylitis

By Lories Rik J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1599-1608

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab for the treatment of ankylosing spondylitis

By Sieper Joachim   Rudwaleit Martin   Braun Jürgen  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 831-838

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis

By Jansen Jeroen P.  

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 323-344

Adis International

Access to resources Recommend Favorite

Celecoxib: A Review of its Use for Symptomatic Relief in the Treatment of Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis

By McCormack Paul L.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2457-2489

Adis International

Access to resources Recommend Favorite

Recent progress in ankylosing spondylitis treatment

By Toussirot Éric   Wendling Daniel  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 1, 2003-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite